Sulfotransferase sequence variants
View Patent ↗Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as sulfotransferase allozymes. Methods for determining if a mammal is predisposed to thyroid disease or cancer also are described.
1. A method for obtaining a SULT1C1 variant profile, wherein said method comprises:
a) providing a biological sample from a human, and
b) detecting the presence or absence of a plurality of SULT1C1 nucleotide sequence variants in said sample to obtain a variant profile of said human, wherein said nucleotide sequence variants are at positions selected from the group consisting of nucleotide 179 of SEQ ID NO:26, nucleotide 218 of SEQ ID NO:26, nucleotide 332 of SEQ ID NO:26, and nucleotide 763 of SEQ ID NO:26.
2. The method of claim 1 , wherein said method further comprises communicating said profile to a medical or research professional.
3. A method for determining the thyroid hormone or 4-nitrophenol sulfonator status of a human subject, said method comprising testing said subject to determine whether said subject comprises a variant SULT1C1 nucleic acid that comprises a nucleotide sequence variant at a position selected from the group consisting of nucleotide 179 of SEQ ID NO:26, nucleotide 218 of SEQ ID NO:26, nucleotide 332 of SEQ ID NO:26, and nucleotide 763 of SEQ ID NO:26.
4. The method of claim 3 , wherein said variant SULT1C1 nucleic acid comprises a cytosine at position 179 of SEQ ID NO:26.
5. The method of claim 3 , wherein said variant SULT1C1 nucleic acid comprises a cytosine at position 218 of SEQ ID NO:26.
6. The method of claim 3 , wherein said variant SULT1C1 nucleic acid comprises a guanine at position 332 of SEQ ID NO:26.
7. The method of claim 3 , wherein said variant SULT1C1 nucleic acid comprises a guanine at position 763 of SEQ ID NO:26.
8. The method of claim 3 , wherein said determining comprises:
wherein said method comprises:
a) providing a biological sample from said subject, and
b) detecting the presence or absence of said SULT1C1nucleotide sequence variant in said sample.